Clinical Experiment

In 2024–25, Dr Lal PathLabs clocked revenues of ₹2,461 crore and annual growth of 10%

Down the Ages: From Partition to Pandemic, How Dr Lal PathLabs Built an Indian Diagnostics Empire

BY Nandini Keshari

Biological E Gets Phase III Trial Nod for its Covid-19 Vaccine

Biological E Gets Phase III Trial Nod for its Covid-19 Vaccine

BY PTI